Abstract Details

Title Memantine for the Treatment of Autism Spectrum Disorder: Overview of the Phase II Clinical Development Program

Topic Child Neurology and Developmental Neurology

Presentation(s) (-)

Poster/Presentation
Number 009

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Jordan Lateiner, MS, MBA	Mr. Lateiner has received personal compensation for serving as an employee of Abbvie. Mr. Lateiner has received stock or an ownership interest from Abbvie.
	No disclosure on file
	No disclosure on file
Simon Borghs	No disclosure on file
Stephen M. Graham, PhD (Forest Laboratories)	No disclosure on file

��ɫ����